Indications
- Prevention of venous thromboembolic events (VTE) in adult patients undergoing elective hip or knee surgery (total hip or knee replacement). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults (see section 4.4 for patients with haemodynamically unstable PE).
API
RIVAROXABAN
Therapeutic area
BLOOD AND HEMATOPOIETIC ORGANS
Forms
Coated tablets
Dosage
10 mg
Presentation
B/30
Table
A